tiprankstipranks

Richard Eisenstadt Insider Profile

11 Followers
Richard Eisenstadt, CFO at Neos Therapeutics, holds 45.01K shares in Altimmune (Ticker: ALT), holds 68.73K shares in Aytu BioScience (Ticker: AYTU), holds 0.00 shares in Neos Therapeutics (Ticker: NEOS).
tipranks
Richard Eisenstadt

Richard Eisenstadt
Neos Therapeutics (NEOS)
CFO

Ranked #21,658 out of 98,624 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+32.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$517K
61.54%
38.46%
A breakdown of Richard Eisenstadt's holdings

Insider Roles

Altimmune
(ALT)
CFO
Aytu BioScience
(AYTU)
Chief Financial Officer
Roles that Richard Eisenstadt holds in companies

Most Profitable Insider Trade

Stock:
Altimmune
(ALT)
Rating:Informative Buy
Date:Mar 24, 2023 - Mar 24, 2024
Return:+110.10%
The most profitable trade made by Richard Eisenstadt

Richard Eisenstadt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NEOS
Neos Therapeutics
Mar 19, 2021
Uninformative Sell
$0.00
Aytu BioScience
Apr 05, 2021
Chief Financial Officer
Uninformative Buy
$198.85K
Altimmune
Feb 01, 2024
CFO
Uninformative Buy
12.43K
$318.23K
OCRX
Ocera Therapeutics
$0.00
List of latest transactions for each holding click on a transaction to see Richard Eisenstadt's performance on stock

Richard Eisenstadt insider profile FAQ

What is the percentage of profitable transactions made by Richard Eisenstadt?
The percentage of profitable transactions made by Richard Eisenstadt is 67%.
    What is the average return per transaction made by Richard Eisenstadt?
    The average return per transaction made by Richard Eisenstadt is 32.20%.
      What stocks does Richard Eisenstadt hold?
      Richard Eisenstadt holds: NEOS, AYTU, ALT, OCRX stocks.
        What was Richard Eisenstadt’s latest transaction?
        Richard Eisenstadt latest transaction was an Uninformative Buy of $12.43K.
          What was Richard Eisenstadt's most profitable transaction?
          Richard Eisenstadt’s most profitable transaction was an Informative Buy of ALT stock on March 24, 2023. The return on the trade was 110.10%.
            What is Richard Eisenstadt's role in Neos Therapeutics?
            Richard Eisenstadt's role in Neos Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.